Therapeutic risk management interventions: feasibility and effectiveness.

Area of Science:

• Pharmacovigilance and Drug Safety
• Health Services Research
• Regulatory Science

Background:

• Significant known risks associated with certain drugs necessitate robust risk management strategies.
• Evaluating the effectiveness and feasibility of these strategies is crucial for patient safety and therapeutic access.

Purpose of the Study:

• To review the effectiveness and feasibility of risk management strategies for drugs with significant known risks.
• To identify gaps in evidence and opportunities for future research in drug risk management.

Main Methods:

• Systematic review of published medical literature and regulatory archives (2002-2003).
• Inclusion of Food and Drug Administration advisory committee meeting proceedings.
• Iterative searches using terms related to risk management, drug safety, and specific medications.

Main Results:

• Evidence on the effectiveness of risk management interventions is largely anecdotal, with limited published data.
• A need exists for evidence-based understanding of whether programs reduce patient risk while ensuring therapy availability.
• Significant opportunities for interdisciplinary research to assess intervention feasibility and impact at multiple levels.

Conclusions:

• Intervention effectiveness hinges on influencing physician prescribing, pharmacist dispensing, and patient adherence.
• Burdensome programs are unlikely to achieve desired risk reduction outcomes.
• Scalable, systematic implementation of risk management is preferred over piecemeal approaches.